Veterinary Vaccines

Veterinary Vaccines


Global Veterinary Vaccines Market to Reach US$14.6 Billion by 2030

The global market for Veterinary Vaccines estimated at US$9.9 Billion in the year 2023, is expected to reach US$14.6 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Poultry Vaccines segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 5.3% CAGR

The Veterinary Vaccines market in the U.S. is estimated at US$2.6 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Veterinary Vaccines Market - Key Trends and Drivers Summarized

Why Are Veterinary Vaccines Crucial for Animal Health?

Veterinary vaccines are essential tools in safeguarding animal health, preventing the spread of infectious diseases, and promoting overall well-being in livestock, pets, and wildlife. These vaccines work by stimulating the animal`s immune system to recognize and combat specific pathogens, reducing the incidence of diseases such as rabies, distemper, parvovirus, and avian influenza. For livestock, vaccinations are critical in ensuring the health of herds and flocks, thereby protecting food supply chains and minimizing economic losses for farmers. In companion animals, vaccines help maintain the health of pets, preventing potentially deadly diseases and reducing the risk of zoonotic infections that can be transmitted to humans. By controlling disease outbreaks, veterinary vaccines play a vital role in public health, food security, and the humane treatment of animals.

Not Just Animals, How  Veterinary Vaccines Protect Us from Zoonotic Diseases?

Veterinary vaccines play a crucial role in reducing the risk of zoonotic diseases, which are infections transmitted from animals to humans. By immunizing animals, these vaccines prevent the initial establishment and subsequent spread of infectious agents among animal populations, thereby acting as a critical barrier against the transmission to humans. For instance, rabies vaccines administered to wildlife and domestic pets have significantly decreased the incidence of this fatal disease in humans. Similarly, vaccinating livestock against diseases like brucellosis and anthrax, which can be transmitted through direct contact or by consuming contaminated animal products, protects human health and enhances food safety. Furthermore, by controlling these diseases in animal populations, veterinary vaccines reduce the environmental load of pathogens, lowering the chance of human exposure and potential outbreaks. This proactive approach not only safeguards public health but also supports the welfare of domestic and wild animal populations, illustrating the intertwined health of humans and animals within shared ecosystems.

How Are Technological Advances Shaping Veterinary Vaccines?

Technological advancements are revolutionizing the field of veterinary vaccines, making them more effective, safer, and easier to administer. Innovations such as recombinant DNA technology and vector-based vaccines have enabled the development of vaccines that offer broader protection and longer-lasting immunity. For instance, subunit vaccines, which include only parts of the pathogen, reduce the risk of adverse reactions while still providing robust immunity. Additionally, advances in adjuvants—substances that enhance the immune response—are improving the efficacy of vaccines, especially in species that are difficult to immunize. Another significant development is the advent of oral and intranasal vaccines, which simplify administration, particularly in large-scale livestock operations. These innovations are not only enhancing the health and productivity of animals but also ensuring more sustainable and efficient agricultural practices.

What Challenges and Trends Are Impacting the Veterinary Vaccine Industry?

The veterinary vaccine industry faces several challenges, including the constant evolution of pathogens and the need for vaccines that can address multiple strains. The emergence of antibiotic-resistant bacteria underscores the importance of vaccines in reducing reliance on antibiotics, thereby mitigating the risk of resistance. Regulatory hurdles also pose significant challenges, as vaccines must undergo rigorous testing to ensure safety and efficacy, which can be time-consuming and costly. Despite these challenges, there are promising trends shaping the industry. There is a growing emphasis on developing vaccines for emerging diseases, supported by advances in genomics and bioinformatics that allow for rapid identification of pathogen targets. Additionally, the integration of big data and artificial intelligence is streamlining vaccine development processes and improving disease surveillance, enabling more proactive and targeted vaccination strategies.

What Drives the Growth in the Veterinary Vaccines Market?

The growth in the veterinary vaccines market is driven by several factors, including increasing pet ownership and the rising demand for animal-derived food products. As more people consider pets part of their family, there is a greater willingness to invest in preventive healthcare, including vaccinations. In the agricultural sector, the intensification of livestock farming and the need to ensure food safety and security drive the demand for effective vaccines to prevent disease outbreaks. Technological advancements that lead to the development of more effective and convenient vaccines also contribute to market expansion. Moreover, heightened awareness of zoonotic diseases and the role of veterinary vaccines in preventing these infections promote the adoption of vaccination programs. Regulatory support and initiatives to control and eradicate animal diseases further stimulate market growth, ensuring that veterinary vaccines remain a critical component of animal healthcare and public health initiatives.

Select Competitors (Total 22 Featured) -
  • Bayer de México SA de CV
  • Biogénesis Bagó SA
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Elanco Animal Health
  • Heska Corporation
  • Indian Immunologicals Ltd.
  • Merck Animal Health
  • Virbac SA
  • Zoetis Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Veterinary Vaccines - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Zoonotic Diseases Drives Demand for Veterinary Vaccines
Innovations in Recombinant and DNA Vaccine Technologies Propel Market Growth
Increasing Awareness of Animal Health and Welfare Bolsters Vaccine Adoption
Global Expansion of Livestock Production and Companion Animal Ownership
Rise in Pet Ownership Bodes Well for Market Growth
Growth in Pet Insurance Market and Veterinary Care Spending
Consumer Trends Towards Organic and Antibiotic-Free Livestock Products
Development of Multivalent Vaccines to Address Multiple Pathogens
Environmental Concerns and the Use of Vaccines in Wildlife Conservation
Innovations in Aquaculture Vaccines Amidst Expanding Fish Farming Operations
Future Prospects in Veterinary Immunotherapy and Personalized Vaccines
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Veterinary Vaccines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Live Attenuated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Recombinant Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Toxoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Other Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
JAPAN
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
CHINA
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
EUROPE
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
FRANCE
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 74: France Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: France Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: France 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
GERMANY
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Germany Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Germany 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 83: Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Germany Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Germany 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
ITALY
TABLE 86: Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Italy Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Italy 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 89: Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Italy Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Italy 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
UNITED KINGDOM
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 92: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: UK Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: UK 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 95: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: UK Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: UK 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of Europe 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of Europe 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 110: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Rest of World Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Rest of World 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2024 & 2030
TABLE 113: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Rest of World Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Rest of World 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings